Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Dow
AstraZeneca
Novartis
Citi
Federal Trade Commission
Medtronic
Daiichi Sankyo
Boehringer Ingelheim
McKinsey

Generated: December 12, 2017

DrugPatentWatch Database Preview

Adenosine - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for adenosine and what is the scope of adenosine patent protection?

Adenosine
is the generic ingredient in three branded drugs marketed by Astellas, Akorn, Fresenius Kabi Usa, Gland Pharma Ltd, Luitpold, Mylan Labs Ltd, Teva Pharms Usa, West-ward Pharms Int, Wockhardt, Aurobindo Pharma Ltd, Emcure Pharms Ltd, Hospira Inc, and Sagent Strides, and is included in twenty NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-six drug master file entries for adenosine. Seventeen suppliers are listed for this compound. There are three tentative approvals for this compound.

Pharmacology for adenosine

Medical Subject Heading (MeSH) Categories for adenosine

Tentative approvals for ADENOSINE

Applicant Application No. Strength Dosage Form
u► Subscribe3MG/MLINJECTABLE; INJECTION
u► Subscribe3MG/MLINJECTABLE; INJECTION
u► Subscribe3MG/MLINJECTABLE; INJECTION
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Mylan Labs LtdADENOSINEadenosineINJECTABLE;INJECTION078640-001Mar 21, 2014APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Hospira IncADENOSINEadenosineSOLUTION;IV (INFUSION)203883-002Mar 24, 2014APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
AkornADENOSINEadenosineINJECTABLE;INJECTION078076-001Oct 31, 2008APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Teva Pharms UsaADENOSINEadenosineINJECTABLE;INJECTION078676-001Jul 31, 2008DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Teva Pharms UsaADENOSINEadenosineSOLUTION;IV (INFUSION)077425-002Aug 29, 2013APRXNoYes► Subscribe► Subscribe► Subscribe► Subscribe
Fresenius Kabi UsaADENOSINEadenosineINJECTABLE;INJECTION077133-001Apr 27, 2005APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
WockhardtADENOSINEadenosineINJECTABLE;INJECTION090220-001Jul 20, 2009DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Hospira IncADENOSINEadenosineSOLUTION;IV (INFUSION)203883-001Mar 24, 2014APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
West-ward Pharms IntADENOSINEadenosineINJECTABLE;INJECTION076501-001Jun 16, 2004DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Sagent StridesADENOSINEadenosineSOLUTION;IV (INFUSION)090212-001Mar 28, 2014APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: adenosine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
AstellasADENOCARDadenosineINJECTABLE;INJECTION019937-002Oct 30, 1989► Subscribe► Subscribe
AstellasADENOSCANadenosineSOLUTION;IV (INFUSION)020059-002May 18, 1995► Subscribe► Subscribe
AstellasADENOSCANadenosineSOLUTION;IV (INFUSION)020059-001May 18, 1995► Subscribe► Subscribe
AstellasADENOSCANadenosineSOLUTION;IV (INFUSION)020059-001May 18, 1995► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
McKesson
Healthtrust
Baxter
Boehringer Ingelheim
Harvard Business School
Fish and Richardson
Cerilliant
Cipla
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot